ARTICLE
|
doi:10.20944/preprints202306.0940.v1
Subject:
Medicine And Pharmacology,
Clinical Medicine
Keywords:
18 months; deep molecular response; nilotinib; newly diagnosed; chronic-phase chronic myeloid leukemia
Online: 13 June 2023 (12:52:05 CEST)
ARTICLE
|
doi:10.20944/preprints202309.0619.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
acute lymphoblastic leukemia; imatinib; dasatinib: nilotinib; ponatinib; blinatumomab; reducedintensity chemotherapy; chemotherapy-free; progression-free
Online: 11 September 2023 (04:05:57 CEST)
ARTICLE
|
doi:10.20944/preprints202307.0060.v1
Subject:
Medicine And Pharmacology,
Medicine And Pharmacology
Keywords:
acute lymphoblastic leukemia; imatinib; ponatinib; dasatinib; nilotinib; blinatumomab; reduced-intensity chemotherapy; chemotherapy-free; progression-free
Online: 7 July 2023 (14:32:15 CEST)
ARTICLE
|
doi:10.20944/preprints201908.0177.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
chronic myeloid leukemia; tyrosine kinase inhibitor; adverse drug event; quality of life; second-generation tyrosine kinase inhibitor; nilotinib
Online: 16 August 2019 (08:09:07 CEST)